SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-225919
Filing Date
2007-10-25
Accepted
2007-10-25 16:50:55
Documents
6
Period of Report
2007-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 25260
2 OFFER LETTER dex1034.htm EX-10.34 11367
3 CHANGE OF CONTROL AGREEMENT dex1035.htm EX-10.35 34166
4 PRESS RELEASE OF THRESHOLD PHARMACEUTICALS, INC. DATED OCTOBER 23, 2007 dex991.htm EX-99.1 4197
5 PRESS RELEASE OF THRESHOLD PHARMACEUTICALS, INC. DATED OCTOBER 24, 2007 dex992.htm EX-99.2 9574
6 GRAPHIC g46183ex99_2.jpg GRAPHIC 16065
  Complete submission text file 0001193125-07-225919.txt   108602
Mailing Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063
Business Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 071191315
SIC: 2834 Pharmaceutical Preparations